These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29547829)

  • 21. Long-term treatment outcome of two patients with pyridoxine-dependent epilepsy caused by ALDH7A1 mutations: normal neurocognitive outcome.
    Nasr E; Mamak E; Feigenbaum A; Donner EJ; Mercimek-Mahmutoglu S
    J Child Neurol; 2015 Apr; 30(5):648-53. PubMed ID: 24789515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemical, structural, and computational analyses of two new clinically identified missense mutations of ALDH7A1.
    Korasick DA; Buckley DP; Palpacelli A; Cursio I; Cesaroni E; Cheng J; Tanner JJ
    Chem Biol Interact; 2024 May; 394():110993. PubMed ID: 38604394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the first knock-out aldh7a1 zebrafish model for pyridoxine-dependent epilepsy using CRISPR-Cas9 technology.
    Zabinyakov N; Bullivant G; Cao F; Fernandez Ojeda M; Jia ZP; Wen XY; Dowling JJ; Salomons GS; Mercimek-Andrews S
    PLoS One; 2017; 12(10):e0186645. PubMed ID: 29053735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A cohort study of pyridoxine-dependent epilepsy and high prevalence of splice site IVS11+1G>A mutation in Chinese patients.
    Xue J; Qian P; Li H; Wu Y; Liu X; Yang Z
    Epilepsy Res; 2015 Dec; 118():1-4. PubMed ID: 26555630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The genotypic spectrum of ALDH7A1 mutations resulting in pyridoxine dependent epilepsy: A common epileptic encephalopathy.
    Coughlin CR; Swanson MA; Spector E; Meeks NJL; Kronquist KE; Aslamy M; Wempe MF; van Karnebeek CDM; Gospe SM; Aziz VG; Tsai BP; Gao H; Nagy PL; Hyland K; van Dooren SJM; Salomons GS; Van Hove JLK
    J Inherit Metab Dis; 2019 Mar; 42(2):353-361. PubMed ID: 30043187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical diagnosis, treatment, and ALDH7A1 mutations in pyridoxine-dependent epilepsy in three Chinese infants.
    Yang Z; Yang X; Wu Y; Wang J; Zhang Y; Xiong H; Jiang Y; Qin J
    PLoS One; 2014; 9(3):e92803. PubMed ID: 24664145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel mutations in pyridoxine-dependent epilepsy.
    Millet A; Salomons GS; Cneude F; Corne C; Debillon T; Jakobs C; Struys E; Hamelin S
    Eur J Paediatr Neurol; 2011 Jan; 15(1):74-7. PubMed ID: 20427214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atypical pyridoxine-dependent epilepsy due to a pseudoexon in ALDH7A1.
    Milh M; Pop A; Kanhai W; Villeneuve N; Cano A; Struys EA; Salomons GS; Chabrol B; Jakobs C
    Mol Genet Metab; 2012 Apr; 105(4):684-6. PubMed ID: 22305855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical, biochemical, and molecular studies in pyridoxine-dependent epilepsy. Antisense therapy as possible new therapeutic option.
    Pérez B; Gutiérrez-Solana LG; Verdú A; Merinero B; Yuste-Checa P; Ruiz-Sala P; Calvo R; Jalan A; Marín LL; Campos O; Ruiz MÁ; San Miguel M; Vázquez M; Castro M; Ferrer I; Navarrete R; Desviat LR; Lapunzina P; Ugarte M; Pérez-Cerdá C
    Epilepsia; 2013 Feb; 54(2):239-48. PubMed ID: 23350806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel mouse model for pyridoxine-dependent epilepsy due to antiquitin deficiency.
    Al-Shekaili HH; Petkau TL; Pena I; Lengyell TC; Verhoeven-Duif NM; Ciapaite J; Bosma M; van Faassen M; Kema IP; Horvath G; Ross C; Simpson EM; Friedman JM; van Karnebeek C; Leavitt BR
    Hum Mol Genet; 2020 Nov; 29(19):3266-3284. PubMed ID: 32969477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pyridoxine-dependent epilepsy owing to antiquitin deficiency--mutation in the ALDH7A1 gene.
    Jagadeesh S; Suresh B; Murugan V; Suresh S; Salomans GS; Struys EA; Jacobs C
    Paediatr Int Child Health; 2013 May; 33(2):113-5. PubMed ID: 23925287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pyridoxine-dependent epilepsy in two Turkish patients in Turkey and review of the literature.
    Gül-Mert G; İncecik F; Hergüner MÖ; Ceylaner S; Altunbaşak Ş
    Turk J Pediatr; 2015; 57(4):394-397. PubMed ID: 27186704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural analysis of pathogenic mutations targeting Glu427 of ALDH7A1, the hot spot residue of pyridoxine-dependent epilepsy.
    Laciak AR; Korasick DA; Gates KS; Tanner JJ
    J Inherit Metab Dis; 2020 May; 43(3):635-644. PubMed ID: 31652343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The EEG response to pyridoxine-IV neither identifies nor excludes pyridoxine-dependent epilepsy.
    Bok LA; Maurits NM; Willemsen MA; Jakobs C; Teune LK; Poll-The BT; de Coo IF; Toet MC; Hagebeuk EE; Brouwer OF; van der Hoeven JH; Sival DA
    Epilepsia; 2010 Dec; 51(12):2406-11. PubMed ID: 20887371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Consensus guidelines for the diagnosis and management of pyridoxine-dependent epilepsy due to α-aminoadipic semialdehyde dehydrogenase deficiency.
    Coughlin CR; Tseng LA; Abdenur JE; Ashmore C; Boemer F; Bok LA; Boyer M; Buhas D; Clayton PT; Das A; Dekker H; Evangeliou A; Feillet F; Footitt EJ; Gospe SM; Hartmann H; Kara M; Kristensen E; Lee J; Lilje R; Longo N; Lunsing RJ; Mills P; Papadopoulou MT; Pearl PL; Piazzon F; Plecko B; Saini AG; Santra S; Sjarif DR; Stockler-Ipsiroglu S; Striano P; Van Hove JLK; Verhoeven-Duif NM; Wijburg FA; Zuberi SM; van Karnebeek CDM
    J Inherit Metab Dis; 2021 Jan; 44(1):178-192. PubMed ID: 33200442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two novel ALDH7A1 (antiquitin) splicing mutations associated with pyridoxine-dependent seizures.
    Striano P; Battaglia S; Giordano L; Capovilla G; Beccaria F; Struys EA; Salomons GS; Jakobs C
    Epilepsia; 2009 Apr; 50(4):933-6. PubMed ID: 18717709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pyridoxine-dependent epilepsy: an under-recognised cause of intractable seizures.
    Yeghiazaryan NS; Zara F; Capovilla G; Brigati G; Falsaperla R; Striano P
    J Paediatr Child Health; 2012 Mar; 48(3):E113-5. PubMed ID: 21496129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pyridoxine-dependent epilepsy with elevated urinary α-amino adipic semialdehyde in molybdenum cofactor deficiency.
    Struys EA; Nota B; Bakkali A; Al Shahwan S; Salomons GS; Tabarki B
    Pediatrics; 2012 Dec; 130(6):e1716-9. PubMed ID: 23147983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pyridoxine-dependent epilepsy due to antiquitin deficiency: achieving a favourable outcome.
    Oliveira R; Pereira C; Rodrigues F; Alfaite C; Garcia P; Robalo C; Fineza I; Gonçalves O; Struys E; Salomons G; Jakobs C; Diogo L
    Epileptic Disord; 2013 Dec; 15(4):400-6. PubMed ID: 24184718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genotype and phenotype features and prognostic factors of neonatal-onset pyridoxine-dependent epilepsy: A systematic review.
    Fang C; Yang L; Xiao F; Yan K; Zhou W
    Epilepsy Res; 2024 May; 202():107363. PubMed ID: 38636407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.